Antitumor immune responses induced by ionizing irradiation and further immune stimulation

Cancer Immunology, Immunotherapy

Volumn 63, Issue 1, 2014, Pages 29-36

  Frey, Benjamin ^a   Rubner, Yvonne ^a   Kulzer, Lorenz ^a   Werthmöller, Nina ^a   Weiss, Eva Maria ^a   Fietkau, Rainer ^a   Gaipl, Udo S ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

CITIM 2013; Damage associated molecular patterns; Dendritic cell; Immune therapy; Immunogenic tumor cell death; Radiotherapy

Indexed keywords

CANCER VACCINE; CELL ADHESION MOLECULE; DEATH RECEPTOR; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; IPILIMUMAB; PACLITAXEL;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL DEATH; CHEMORADIOTHERAPY; CROSS PRESENTATION; DENDRITIC CELL; DNA DAMAGE; ENDOPLASMIC RETICULUM; GLIOBLASTOMA; HUMAN; HYDROSTATIC PRESSURE; IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSTIMULATION; IONIZING IRRADIATION; IRRADIATION; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; TUMOR CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR NECROSIS;

EID: 84891849910     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-013-1474-y     Document Type: Review

References (52)

1. Weiss EM, Wunderlich R, Ebel N et al (2012) Selected anti-tumor vaccines merit a place in multimodal tumor therapies. Front Oncol 2:132. doi: 10.3389/fonc.2012.00132
2. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12:253-268. doi: 10.1038/nri3175
3. Frey B, Rubner Y, Wunderlich R, Weiss EM, Pockley AG, Fietkau R, Gaipl US (2012) Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation: implications for cancer therapies. Curr Med Chem 19:1751-1764
4. Apetoh L, Ghiringhelli F, Tesniere A et al (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13:1050-1059. doi: 10.1038/nm1622 (Pubitemid 47517504)
5. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I (1997) Immunosuppressive effects of apoptotic cells. Nature 390:350-351. doi: 10.1038/37022 (Pubitemid 28027305)
6. Gregory CD, Pound JD (2010) Microenvironmental influences of apoptosis in vivo and in vitro. Apoptosis 15:1029-1049. doi: 10.1007/s10495-010-0485-9
7. Lauber K, Ernst A, Orth M, Herrmann M, Belka C (2012) Dying cell clearance and its impact on the outcome of tumor radiotherapy. Front Oncol 2:116. doi: 10.3389/fonc.2012.00116
8. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P (2012) Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12:860-875. doi: 10.1038/nrc3380
9. Hagemann T, Balkwill F, Lawrence T (2007) Inflammation and cancer: a double-edged sword. Cancer Cell 12:300-301. doi: 10.1016/j.ccr.2007.10.005 (Pubitemid 47539316)
10. Schildkopf P, Frey B, Ott OJ, Rubner Y, Multhoff G, Sauer R, Fietkau R, Gaipl US (2011) Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother Oncol 101:109-115. doi: 10.1016/j.radonc.2011.05.056
11. Ma Y, Adjemian S, Mattarollo SR et al (2013) Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 38:729-741. doi: 10.1016/j.immuni.2013.03.003
12. Frey B, Gaipl US (2011) The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin Immunopathol 33:497-516. doi: 10.1007/s00281-010-0228-6
13. Bondanza A, Zimmermann VS, Rovere-Querini P et al (2004) Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med 200:1157-1165. doi: 10.1084/jem.20040327 (Pubitemid 39507055)
14. Gaipl US, Beyer TD, Baumann I, Voll RE, Stach CM, Heyder P, Kalden JR, Manfredi A, Herrmann M (2003) Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal-implications for antiphospholipid syndrome and systemic lupus erythematosus. Immunobiology 207:73-81. doi: 10.1078/0171-2985-00217 (Pubitemid 36285099)
15. Frey B, Schildkopf P, Rodel F, Weiss EM, Munoz LE, Herrmann M, Fietkau R, Gaipl US (2009) AnnexinA5 renders dead tumor cells immunogenic-implications for multimodal cancer therapies. J Immunotoxicol 6:209-216. doi: 10.3109/15476910903204058
16. Michels T, Shurin GV, Naiditch H, Sevko A, Umansky V, Shurin MR (2012) Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner. J Immunotoxicol 9:292-300. doi: 10.3109/1547691x.2011.642418
17. Timke C, Winnenthal HS, Klug F et al (2011) Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer. BMC Cancer 11:134. doi: 10.1186/1471-2407-11-134
18. Postow MA, Callahan MK, Barker CA et al (2012) Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366:925-931. doi: 10.1056/NEJMoa1112824
19. Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707-1716. doi: 10.1016/s0140-6736(11)61629-2
20. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, Formenti SC (2004) Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 58:862-870. doi: 10.1016/j.ijrobp.2003.09.012 (Pubitemid 38221143)
21. Frey B, Lotter M, Stangl S, Rodel F, Fietkau R, Gaipl US (2012) Adaptive and innate immune cells contribute to reduced tumor progression after local irradiation of CT26 tumors in Balb/c mice. Strahlenther Onkol 188 [Abstractband zur 18. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO)]:132
22. Bogdandi EN, Balogh A, Felgyinszki N, Szatmari T, Persa E, Hildebrandt G, Safrany G, Lumniczky K (2010) Effects of low-dose radiation on the immune system of mice after total-body irradiation. Radiat Res 174:480-489. doi: 10.1667/rr2160.1
23. Wunderlich R, Frischholz B, Roedel F, Fietkau R, Frey B, Gaipl US (2013) Ionising radiation with single doses up to clinical relevant 2Gy does not influence viability and phagocytosis capability of single activated macrophages of radiosensitive BALB/c mice. Strahlenther Onkol 189 [Abstractband zur 19. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO)]:122
24. Bauer M, Goldstein M, Heylmann D, Kaina B (2012) Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant. PLoS One 7:e39956. doi: 10.1371/journal.pone.0039956
25. Bauer M, Goldstein M, Christmann M, Becker H, Heylmann D, Kaina B (2011) Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc Natl Acad Sci USA 108:21105-21110. doi: 10.1073/pnas.1111919109
26. Lee Y, Auh SL, Wang Y et al (2009) Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114:589-595. doi: 10.1182/blood-2009-02-206870
27. Gupta A, Probst HC, Vuong V et al (2012) Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation. J Immunol 189:558-566. doi: 10.4049/jimmunol.1200563
28. Frey B, Weber J, Kohn K, Lotter M, Stangl S, Rodel F, Fietkau R, Gaipl US (2013) Hypofractionated local radiotherapy induces a timely restricted infiltration of immune cells in CT26 colon cancer tumors of BALB/c mice. Strahlenther Onkol 189 [Abstractband zur 19. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO)]:116
29. Ma Y, Aymeric L, Locher C et al (2011) Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med 208:491-503. doi: 10.1084/jem.20100269
30. Takeshima T, Chamoto K, Wakita D, Ohkuri T, Togashi Y, Shirato H, Kitamura H, Nishimura T (2010) Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res 70:2697-2706. doi: 10.1158/0008-5472.can-09- 2982
31. Matsunaga A, Ueda Y, Yamada S, Harada Y, Shimada H, Hasegawa M, Tsujii H, Ochiai T, Yonemitsu Y (2010) Carbon-ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma. Cancer 116:3740-3748. doi: 10.1002/cncr.25134
32. Weiss EM, Meister S, Janko C et al (2010) High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features. J Immunotoxicol 7:194-204. doi: 10.3109/15476911003657414
33. Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH (2007) Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 7:1705-1721. doi: 10.1517/14712598.7.11.1705 (Pubitemid 350157496)
34. Kerkar SP, Goldszmid RS, Muranski P et al (2011) IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J Clin Invest 121:4746-4757. doi: 10.1172/jci58814
35. Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A (2012) Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med 209:2351-2365. doi: 10.1084/jem.20120944
36. Hodge JW, Sharp HJ, Gameiro SR (2012) Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation. Cancer Biother Radiopharm 27:12-22. doi: 10.1089/cbr.2012.1202
37. Formenti SC, Demaria S (2013) Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 105:256-265. doi: 10.1093/jnci/djs629
38. Weng D, Song B, Koido S, Calderwood SK, Gong J (2013) Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation. J Immunol 191:755-763. doi: 10.4049/jimmunol.1203286
39. Wheeler CJ, Black KL, Liu G et al (2008) Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients. Cancer Res 68:5955-5964. doi: 10.1158/0008-5472.can-07-5973
40. Van Gool S, Maes W, Ardon H, Verschuere T, Van Cauter S, De Vleeschouwer S (2009) Dendritic cell therapy of high-grade gliomas. Brain Pathol 19:694-712. doi: 10.1111/j.1750-3639.2009.00316.x
41. Muth C, Schmidt V, Rubner Y, Fietkau R, Semrau S, Buslei R, Gaipl US (2013) Comparative analysis of the danger signals HMGB1, Hsp70, and Calreticulin in primary tumors and relapses of glioblastoma patients. Strahlenther Onkol 189 [Abstractband zur 19. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO)]:124
42. Rubner Y, Sieber R, Buslei R, Fietkau R, Frey B, Gaipl US (2013) Fractionated radiotherapy and not chemotherapy with temozolomide and/or valproic acid is the main stimulus for the induction of immunogenic glioma cell death in p53 mutated glioma cell lines. Strahlenther Onkol 189 [Abstractband zur 19. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO)]: 115-116
43. Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, Multhoff G (2005) Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 65:5238-5247. doi: 10.1158/0008-5472.can-04-3804 (Pubitemid 40827334)
44. Durante M, Reppingen N, Held KD (2013) Immunologically augmented cancer treatment using modern radiotherapy. Trends Mol Med. doi: 10.1016/j.molmed.2013. 05.007
45. Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, Demaria S (2009) Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 15:5379-5388. doi: 10.1158/1078-0432.ccr-09-0265
46. Schaue D, Ratikan JA, Iwamoto KS, McBride WH (2012) Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys 83:1306-1310. doi: 10.1016/j.ijrobp.2011.09.049
47. Kulzer L, Schaft N, Dorrie J, Rubner Y, Frey B, Gaipel U, Fietkau R (2013) Influence of fractionated and hypofractionated radiotherapy on the activation of human dendritic cells. Strahlenther Onkol 189 [Abstractband zur 19. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO)]:119
48. Vanneman M, Dranoff G (2012) Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 12:237-251. doi: 10.1038/nrc3237
49. Mantel F, Frey B, Haslinger S et al (2010) Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells. Strahlenther Onkol 186:587-599. doi: 10.1007/s00066-010-2154-x
50. Werthmoller N, Frey B, Fietkau R, Gaipl US (2013) The influence of standard combinatory tumor treatments and the apoptosis inhibitor zVAD-fmk on B16 melanoma cell death forms and consecutively on macrophages and dendritic cells. Strahlenther Onkol 189 [Abstractband zur 19. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO)]:120
51. Scheithauer HR, Schulz DS, Belka C (2011) Endometrial cancer: reduce to the minimum. A new paradigm for adjuvant treatments? Radiat Oncol 6:164. doi: 10.1186/1748-717x-6-164
52. Sckisel GD, Murphy WJ (2012) Specificity may be overrated in cancer immunotherapy: getting to know the nonspecific side of memory T Cells. Oncoimmunology 1:1208-1210. doi: 10.4161/onci.20779